REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Metro Clinical Practise Group Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores | Ambulatory Health Care Services | Other Services (except Public Administration)
Full name: Metro Clinical Practise Group Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Metro Clinical Practise Group Sdn. Bhd. is based in Malaysia. The head office is in Shah Alam. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on May 09, 2016. The company’s latest financial report indicates a net sales revenue drop of 7.03% in 2023. Its’ total assets recorded a growth of 6.91%. In 2023, Metro Clinical Practise Group Sdn. Bhd.’s net profit margin decreased by 9.48%.

Headquarters
No. 31/1, Jalan Anggerik Vanilla Be31/Be, Kota Kemuning
Shah Alam; Selangor; Postal Code: 40460

Contact Details: Purchase the Metro Clinical Practise Group Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Metro Clinical Practise Group Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Metro Clinical Practise Group Sdn. Bhd. report to view the information.
Incorporation Date:
May 09, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
99.8%
Purchase this report to view the information.
0.2%
Company Performance
Financial values in the chart are available after Metro Clinical Practise Group Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-7.03%▼
Total operating revenue
-7.03%▼
Operating profit (EBIT)
-64.11%▼
EBITDA
-57.83%▼
Net Profit (Loss) for the Period
-91.82%▼
Total assets
6.91%▲
Total equity
1.83%▲
Operating Profit Margin (ROS)
-9.65%▼
Net Profit Margin
-9.48%▼
Return on Equity (ROE)
-20.53%▼
Quick Ratio
-0.13%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo